| Browse by: | Sort by: |
PCOS: What's Metabolic Dysfunction Got to Do with It?
PCOS in the Omics Age: Contribution to the Understanding of Female Metabolic Dysfunction
Hector Francisco Escobar-Morreale, MD, PhD
Diabetes, Obesity and Human Reproduction Research Group. Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, CIBER Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Spanish Ministry of Science, Madrid, Spain
Available
PCOS: What's Metabolic Dysfunction Got to Do with It?
PCOS in the Wild
Ricardo Azziz, MD, MPH, MBA
Augusta University, Augusta, GA
Available
PCOS: What's Metabolic Dysfunction Got to Do with It?
Androgens, PCOS, and Adipocyte Function
Elisabet Stener-Victorin, PhD
Karolinska Institutet, Stockholm, Sweden
Available
Intensive Weight Management
Intensive Weight Management
Daniel H. Bessesen, MD
University of Colorado School of Medicine, Anschutz Medical Campus, Denver, CO
Available
Lipodystrophy Syndromes
Lipodystrophy Syndromes
Abhimanyu Garg, MD
University of Texas SW Medical Center, Dallas, TX
Available
Pediatric Obesity: Mechanisms, Consequences, and Novel Treatment Approaches
Full or Hungry: How Does Your Brain Know?
Joan C Han, MD
University of Tennessee Health Science Center, Memphis, TN
Available
Pediatric Obesity: Mechanisms, Consequences, and Novel Treatment Approaches
Management of Non-Glycemic Consequences of Obesity
Tamara S Hannon, MD
Indiana University School of Medicine, Indianapolis, IN
Available
The Consequences of Ectopic Fat Deposition in the Liver
The Metabolic Effects of Dysfunctional Fatty Acid Metabolism in Obesity
Amalia Gastaldelli, PHD
CNR, Inst of Clinical Physiology, Pisa, Italy
Available
The Consequences of Ectopic Fat Deposition in the Liver
Heterogeneity of NAFLD - Implications for the Clinic
Hannele Yki-Jarvinen, MD FRCP
University of Helsinki, Helsinki, Finland
Permission not
granted for presentation
granted for presentation
The Consequences of Ectopic Fat Deposition in the Liver
Imaging-Based Non-Invasive Diagnosis of NASH
Richard L. Ehman, MD
Mayo Clinic, Rochester, MN
Coming soon
Metabolism Bites Back: Why Am I Regaining Weight?
Metabolic Set Point of Body Weight
Rudolph L Leibel, MD
Columbia University, New York, NY
Available
Metabolism Bites Back: Why Am I Regaining Weight?
Appetite and Metabolic Adaptations to Weight Loss and Their Contribution to Weight Regain
Kevin D. Hall, PhD
NIH, Bethesda, MD
Available
Metabolism Bites Back: Why Am I Regaining Weight?
Weight Regulation after Bariatric Surgery
Judith Korner, MD, PhD
Columbia University College of Physicians & Surgeons, New York, NY
Permission not
granted for presentation
granted for presentation
What Can a Clinician Learn from Genetic Obesity Syndromes?
What Can a Clinician Learn from Genetic Obesity Syndromes?
Joan C Han, MD
University of Tennessee Health Science Center, Memphis, TN
Available
Gastrointestinal Hormones in the Treatment of Disease
GLP-1 and GLP-2 in the Treatment of Metabolic Diseases
Patricia Lee Brubaker, Ph.D.
University of Toronto, Toronto, ON
Available
Gastrointestinal Hormones in the Treatment of Disease
PYY and the Treatment of Obesity
Rachel L Batterham
University College London, London, United Kingdom
Permission not
granted for presentation
granted for presentation
Gastrointestinal Hormones in the Treatment of Disease
Gastrointestinal Peptide-Based Strategies to Treat Obesity
Matthias Hans Tschöp, MD
Helmholtz Zentrum München and Technische Universität München, Garching, Germany
Available
Craniopharyngioma and Its Aftermath: An Update on a Benign Tumor That is Not So “Benign”
Craniopharyngioma Pathophysiology and Clinical Presentation
Niki Karavitaki, MSc, PhD, FRCP
Institute of Metabolism and Systems Research, University of Birmingham and Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, United Kingdom
Available
Craniopharyngioma and Its Aftermath: An Update on a Benign Tumor That is Not So “Benign”
Contemporary Approaches to Craniopharyngioma Treatment and Clinical Outcomes
Hermann L Muller, MD
Klinikum Oldenburg AöR, Medical Campus University Oldenburg, Oldenburg, Germany
Available
Craniopharyngioma and Its Aftermath: An Update on a Benign Tumor That is Not So “Benign”
Hypothalamic Obesity: Mechanisms of Disease and Approaches to Management
Christian Ludwig Roth, MD
Seattle Children's Hospital, Seattle, WA
Available
The Sugar Tax: Can We Really Legislate Weight Loss?
The Epidemiologist's Perspective
Michael Long, SD, MPH
The George Washington University, Washington, DC
Available
The Sugar Tax: Can We Really Legislate Weight Loss?
The Economist's Perspective
Shu Wen Ng, PhD
University of North Carolina, Chapel Hill, NC
Available
The Sugar Tax: Can We Really Legislate Weight Loss?
Obesity: What Policies Address It and How Well Do They Work?
Brian Elbel, PhD, MPH
NYU School of Medicine, New York, NY
Available
Care of Post Bariatric Surgery Patients: The Good, the Bad and the Ugly
Care of Post Bariatric Surgery Patients: The Good, the Bad and the Ugly
Todd Andrew Kellogg, MD
Mayo Clinic, Rochester, MN
Maria L Collazo-Clavell, MD
Mayo Clinic, Rochester, MN
Available
Statin Intolerance
Statin Intolerance
Connie Newman, MD
NYU School of Medicine, New York, NY
Available
